This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Hemispherx BioPharma, trading on the NYSE American under the ticker symbol HEB, ...
This article was generated by an automated content engine and was reviewed by a ...
This article was generated by an automated content engine and was reviewed by a ...
This article was generated by an automated content engine and was reviewed by a ...
Microbot Medical Inc. (NASDAQ: MBOT) recently disclosed its entry into Securitie...
On February 11, 2025, QHSLab, Inc. (USAQ) revealed a strategic co-marketing part...
On February 11, 2025, Sensus Healthcare, Inc. (NASDAQ: SRTS) announced the reviv...
On February 11, 2025, Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) filed a Form ...
Stran & Company, Inc. (NASDAQ: STRNW), a marketing solutions provider specializi...
This article was generated by an automated content engine and was reviewed by a ...
U.S. Gold Corp. (NASDAQ: USAU) recently released details of its updated pre-feas...
Walgreens Boots Alliance, Inc., the prominent pharmacy chain, disclosed signific...
Byrna Technologies Inc. (NASDAQ:BYRN – Free Report) – Analysts at Roth Capital r...
Zotefoams plc (LON:ZTF – Get Free Report) insider Gary McGrath bought 50 shares ...
![Humana (NYSE:HUM) Files 8-K with SEC Detailing Material EventHealthcare giant Humana (NYSE:HUM) has filed an 8-K form with the Securities and Exchange Commission (SEC) on [insert date]. The filing lays out a material event in the company’s operations](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/humana-inc-logo-1200x675.png?v=20231226131443&w=240&h=240&zc=2){kind=logo}
This article was generated by an automated content engine and was reviewed by a ...
This article was generated by an automated content engine and was reviewed by a ...